Drug research

ARCT-810

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
A Study to Evaluate the Pharmacodynamics and Safety of ARCT-810 in Participants With OTCDNCT06488313	Arcturus Therapeutics, Inc.	Phase 2	Recruiting	2026-06-01Estimated
Study for Adolescents and Adults With Ornithine Transcarbamylase Deficiency to Evaluate Safety and Tolerability of ARCT-810NCT05526066	Arcturus Therapeutics, Inc.	Phase 2	Terminated	2024-10-31Actual

Arcturus Therapeutics, Inc.RecruitingPrimary completion: 2026-06-01 · Estimated

Trial details

Arcturus Therapeutics, Inc.TerminatedPrimary completion: 2024-10-31 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.